The association of UBE2C with RBP7, alongside other upregulated genes such as TK1 and TYMS, underscores its potential role in hepatocellular carcinoma progression and highlights UBE2C as a critical target for therapeutic intervention in this context [48]. Here, UBE2C is linked to hepatocellular carcinoma.